Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayman Tourbah

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 2015
Biotin and demyelinating diseases--a new connection?Ayman Tourbah
La Revue Du Praticien|December 5, 2018
[Which prognostic criteria in multiple sclerosis?]Ayman Tourbah
Presse Medicale (Paris, France : 1983)|November 23, 2007
[Natalizumab in multiple sclerosis: the second treatment revolution]Ayman Tourbah
Annals of Neurology|February 5, 2014
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosisOlivier Gout, Ayman Tourbah
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2017
Reply to the letter: Biotinidase deficiency masquerading as multiple sclerosis?Ayman Tourbah, Frédéric Sedel
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2016
Reply to Letter to the Editor: Biotin supplementation in MS clinically valuable but can alter multiple blood test results by Siddiqui U, et alAyman Tourbah, Frédéric Sedel
Multiple Sclerosis and Related Disorders|February 8, 2018
Letter to the Editors - Multiple sclerosis and related disorders - Birnbaum et al., 2017Ayman Tourbah, Frederic Sedel
Biochimie|June 19, 2007
Interferons in multiple sclerosis: ten years' experienceAyman Tourbah, Olivier Lyon-Caen
Neuropharmacology|September 2, 2015
Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosisFrédéric Sedel, Delphine Bernard, Donald M Mock, et al.
Journal of Neuropsychology|May 14, 2021
Social cognition and executive functioning in multiple sclerosis: A cluster-analytic approachAudrey Henry, Séverine Lannoy, Marie-Pierre Chaunu, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 2015
Biotin and demyelinating diseases--a new connection?Ayman Tourbah
La Revue Du Praticien|December 5, 2018
[Which prognostic criteria in multiple sclerosis?]Ayman Tourbah
Presse Medicale (Paris, France : 1983)|November 23, 2007
[Natalizumab in multiple sclerosis: the second treatment revolution]Ayman Tourbah
Annals of Neurology|February 5, 2014
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosisOlivier Gout, Ayman Tourbah
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 25, 2017
Reply to the letter: Biotinidase deficiency masquerading as multiple sclerosis?Ayman Tourbah, Frédéric Sedel
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2016
Reply to Letter to the Editor: Biotin supplementation in MS clinically valuable but can alter multiple blood test results by Siddiqui U, et alAyman Tourbah, Frédéric Sedel
Multiple Sclerosis and Related Disorders|February 8, 2018
Letter to the Editors - Multiple sclerosis and related disorders - Birnbaum et al., 2017Ayman Tourbah, Frederic Sedel
Biochimie|June 19, 2007
Interferons in multiple sclerosis: ten years' experienceAyman Tourbah, Olivier Lyon-Caen
Neuropharmacology|September 2, 2015
Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosisFrédéric Sedel, Delphine Bernard, Donald M Mock, et al.
Journal of Neuropsychology|May 14, 2021
Social cognition and executive functioning in multiple sclerosis: A cluster-analytic approachAudrey Henry, Séverine Lannoy, Marie-Pierre Chaunu, et al.
Pageof 6